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ABSTRACT
ConsensusPathDB is a meta-database that inte-
grates different types of functional interactions
from heterogeneous interaction data resources.
Physical protein interactions, metabolic and sig-
naling reactions and gene regulatory interactions
are integrated in a seamless functional association
network that simultaneously describes multiple
functional aspects of genes, proteins, complexes,
metabolites, etc. With 155432 human, 194480
yeast and 13648 mouse complex functional inter-
actions (originating from 18 databases on human
and eight databases on yeast and mouse inter-
actions each), ConsensusPathDB currently consti-
tutes the most comprehensive publicly available
interaction repository for these species. The Web
interface at http://cpdb.molgen.mpg.de offers dif-
ferent ways of utilizing these integrated interaction
data, in particular with tools for visualization,
analysis and interpretation of high-throughput ex-
pression data in the light of functional interactions
and biological pathways.
INTRODUCTION
Knowledge of the functional interactions between physical
entities in the cell has high explanatory power regarding
biological processes in health and disease (1). Thus,
numerous methods for mapping functional association
networks such as physical protein interaction networks,
metabolic and signaling pathways and gene regulatory
networks have been applied in many organisms. The
data resulting from such analyses are currently
interspersed in hundreds of databases that typically
contain only a single aspect of functional interactions of
genes, proteins, etc. (2). For example, some databases are
specialized on storing protein–protein interaction data,
while others focus on the curation of biochemical
pathways and still others on gene regulatory interactions.
In the cell, however, all different types of functional inter-
actions are operative at the same time: to give an example
scenario, genes are regulated to produce proteins that
interact physically with other proteins to form complexes
that catalyze metabolic reactions. ConsensusPathDB,
which we previously reported in (3), assembles a func-
tional association network from multiple heterogeneous
public interaction resources by integrating physical
entities based on their accession numbers and functional
interactions based on their participants. As the combined
interaction network in ConsensusPathDB reveals multiple
functional aspects of cellular entities at the same time
by combining highly complementary data, it is closer to
biological reality than the separate source networks.
The content of ConsensusPathDB can be exploited in
different ways and contexts through its public Web inter-
face at http://cpdb.molgen.mpg.de. It features interaction
querying and visualization, network validation and several
tools for the interaction- and pathway-level interpretation
of user-speciﬁed gene or protein expression data.
In this database update report, we highlight the major
extensions of ConsensusPathDB regarding database
content and functionality of its Web interface.
DATABASE CONTENT: NEW SOURCE
DATABASES, NEW INTERACTIONS AND NEW
TAXONOMIC SPECIES
Since the previous database report (3), the human inter-
action content of ConsensusPathDB has been increased
signiﬁcantly (Figure 1, left panel). Due to the integration
of six additional interaction data resources and updates on
the previously integrated 12 resources, the human inter-
action data in ConsensusPathDB have more than doubled
from 74289 to 155432 unique complex functional inter-
actions. The newly integrated data include complex
protein interactions from Corum (4), large-scale protein
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IntAct-LS), manually curated protein–protein interactions
from MIPS-MPPI (6), protein–protein interactions
from the Pathogen Interaction Gateway (PIG) meta-
database (7), the Edinburgh Human Metabolic Network
reconstruction (EHMN) (8) and biological pathways
from INOH (http://www.inoh.org). We have additionally
imported 5238 physical interactions between human tran-
scription factors published recently in ref. 9. Furthermore,
pathway deﬁnitions in the form of lists of genes
participating in biological pathways were imported from
PharmGKB (10) for use in pathway-based analysis
of expression data. With the addition of PIG, 20098
host–pathogenic protein–protein interactions were
introduced into ConsensusPathDB involving proteins
from 864 viral and bacterial species. Thus, the integrated
ConsensusPathDB network can now additionally serve as
explanatory basis in the context of infectious diseases.
Table 1 shows the number of human interactions
imported from each database, as well as the pairwise
overlaps of source databases. To assess these overlaps and
to avoid redundant interactions in ConsensusPathDB,
physical entities and functional interactions from source
databases are mapped to each other. The mapping process
is detailed in Supplementary Data.
Apart from extending the human functional interaction
network, we have created ConsensusPathDB instances
for two more organisms: Saccharomyces cerevisiae and
Mus musculus, integrating eight interaction resources
each: Reactome (11), KEGG (12), BioCyc (13), IntAct
(5), DIP (14), MINT (15), BioGRID (16) and MIPS
(6,17). The mouse instance additionally includes
1145 interactions between mouse transcription factors
obtained from ref. 9. As in the case of the human
ConsensusPathDB instance, only metabolic reactions
have been imported from KEGG in the mouse and yeast
database instances. This is due to the fact that signaling
reactions are not made available by KEGG in any
computer-readable format. However, KEGG’s signaling
pathways are stored in ConsensusPathDB in the form of
gene lists for use in the context of gene expression analyses
described below.
Overall, ConsensusPathDB currently contains 41271
physical entities, 155432 functional interactions and
2205 biological pathways in human; 14532 physical
entities, 194480 functional interactions and 734 biological
pathways in yeast; and 21946 physical entities, 13648
functional interactions and 1381 biological pathways in
mouse. The numbers correspond to the content after inte-
gration, i.e. unique item counts (for example, the number
of non-unique human interactions before integration is
306003). Our meta-database is updated every 3 months
with the newest releases of its interaction resources.
For the vast majority of functional interactions and
physical entities, annotation in the form of literature ref-
erences and sequence database identiﬁers, respectively, is
imported from the source databases. Literature references
are especially useful for protein–protein interactions, as
they often serve for interaction conﬁdence estimations.
We do not make any judgments on the quality of inter-
actions: all interactions from all source databases are
treated equally. For example, physical interactions
detected by both large-scale and small-scale experiments
are accommodated in ConsensusPathDB without
Figure 1. ConsensusPathDB content and Web interface functionality. Content and features that have been described in our previous database report
(3) are displayed in gray font, new items in black. The plot in the left panel shows the growth of the human interaction data in ConsensusPathDB
since the last database report (ConsensusPathDB release 7, 74289 interactions) through the releases until present (release 16, 155432 interactions).
Source database additions that contribute interactions to ConsensusPathDB are listed under the corresponding release in the plot.
Nucleic Acids Research, 2011,Vol.39, Database issue D713applying any interaction ﬁltering. The ConsensusPathDB
users can themselves opt to use ﬁltering based, e.g. on the
number of publications, the scale of the interaction detec-
tion method or the number of source databases per inter-
action, since this information is stored and provided in
ConsensusPathDB.
For all physical entities, interactions and pathways, the
different source databases are recorded and links to the
original data are provided where applicable.
NEW WEB SERVER FUNCTIONALITY
Apart from boosting the interaction content in the
ConsensusPathDB repository, we have further developed
its publicly accessible Web interface (http://cpdb.molgen.
mpg.de) to add new functionality (Figure 1, right panel).
This includes mainly (i) an advanced, more ﬂexible
network visualization framework that features for
example overlay of expression values on physical entity
nodes and (ii) new facilities in the gene expression data
analysis context for the detection of interaction sub-
networks and other functional gene groups that have
changed activity between phenotypes.
Network visualization
After searching for interactions of particular physical
entities, biological pathways or shortest paths of inter-
actions connecting any two physical entities from
ConsensusPathDB, the Web interface user has presently
two choices for visualizing selected interactions. These
choices include the previously described, static-image-
based visualization framework and a new, Java-applet-
based framework. Both frameworks display interaction
networks in the same style, so switching between them
involves hardly any user acclimatization. While the latter
framework requires a Java Runtime Environment to be
installed on the client computer and thus has higher
processor and workspace requirements than a simple
computer image, it has several advantages, especially
when it comes to visualizing larger networks. Network
nodes (physical entities/functional interactions) are
movable and can be rearranged automatically using differ-
ent layout methods. Network viewing is further facilitated
through the zoom function controlled by the computer
mousewheel.InthisJava-basedvisualizationenvironment,
gene/protein expression data can be overlaid on the nodes
of a currently viewed network to enable the interaction
network-based interpretation of these data (Figure 2).
Network- and pathway-based analysis of gene
expression data
Using the Web interface of ConsensusPathDB, gene ex-
pression data can be analyzed with statistical methods on
the level of predeﬁned functional gene sets. These gene sets
are based on neighborhood in the functional interaction
network, cooperation in curated biochemical pathways or,
since recently, co-annotation with Gene Ontology (18)
categories. One possibility to interpret the gene expression
data is through gene set over-representation analysis—a
functionality that we have described in our previous
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D714 Nucleic AcidsResearch, 2011, Vol.39, Database issuedatabase report (3). Here, the user uploads a list of genes
that are differentially expressed in a phenotype of interest,
typically a disease phenotype, compared to a control
phenotype. Based on the hypergeometric test, predeﬁned
functional gene sets such as pathways or interaction
sub-networks are identiﬁed that contain signiﬁcantly
many of the uploaded genes of interest. For example, if
differentially expressed genes are over-represented in a
network region, this can be an indicator that this region
may be dysregulated in the phenotype in question. In
addition to over-representation analysis, we have imple-
mented a gene set enrichment analysis method, which we
have reported in (19). In this approach, denoted Wilcoxon
enrichment analysis, the complete set of measured genes is
uploaded with two expression values per gene, rather than
just a non-weighted list of genes that pass a signiﬁcance
threshold as in the case of over-representation analysis.
The per-gene values typically represent gene expression
levels in the two phenotypes being compared. For every
predeﬁned gene set, a Wilcoxon signed-rank test is
calculated to evaluate the joint expression difference of
the whole predeﬁned gene set rather than individual
genes. In other words, even if a predeﬁned functional
gene set, such as a pathway, contains no genes with sig-
niﬁcant differential expression, the joint expression of the
group of genes may be signiﬁcantly changed, indicating
potential pathway deregulation on a low but nonetheless
consistent gene level.
Use case: functional network-based analysis of gene
expression data
To demonstrate the utility of the new Wilcoxon enrich-
ment analysis functionality and the overlay of expression
values on interaction networks within the new Java
network visualization environment, we applied these
tools on gene expression measurements from Yu et al.
(20) comparing prostate carcinoma against metastatic
prostate cancer patients. The Yu et al. data were
Figure 2. A functional interaction sub-network visualized by ConsensusPathDB’s new network visualization framework. This sub-network deﬁnes
the neighborhood-based entity set centered by SUV39H2 (Histone H3-K9 methyltransferase 2, highlighted with red frame in the network) and
containing its direct physical interactors, as well as enzymes of neighboring biochemical reactions. The network consists of 13 physical interactions
(orange circles) and ﬁve biochemical reactions (green circles) from nine different databases (interaction origins are encoded as edge colors). Gene
expression data by Yu et al. (20) are overlaid as log2(fold change) values on the physical entity nodes (rectangles). Protein products of measured
genes are colored according to the fold expression change (see legend), the rest of the physical entities in the network are gray. Based on the Yu et al.
data, the Wilcoxon enrichment analysis tool of ConsensusPathDB suggests that members of this neighborhood-based entity set show jointly
signiﬁcant increase in transcription levels in metastatic prostate cancer compared to primary prostate carcinoma.
Nucleic Acids Research, 2011,Vol.39, Database issue D715downloaded from Oncomine 3.0 (21) in February 2009.
These data constitute gene expression measurements in 64
prostate carcinoma samples and 25 metastatic prostate
cancer samples and are summarized in Oncomine in the
form of mean normalized gene expression values for the
two sample cohorts, as well as a t-test P-value reﬂecting
the signiﬁcance of differential gene expression. We add-
itionally ﬁltered the data to exclude ESTs and ambiguously
identiﬁed genes. For Wilcoxon enrichment analysis in
ConsensusPathDB, we uploaded the resulting list of 7807
genes together with their mean expression values for both
patient cohorts. We selected interaction neighborhood-
based entity sets of radius 1, curated pathways, and Gene
Ontology level 3 biological process categories as predeﬁned
functional sets for enrichment analysis with default param-
eter settings. Results, summarized in Supplementary
Table S1, clearly correspond to the hallmarks of human
cancer (22): changes in the cell cycle, transcription, trans-
lation, signaling, angiogenesis and immune response. For
example, among the pathways whose activity is signiﬁcant-
ly changed in metastatic cancer compared to primary car-
cinoma according to the Wilcoxon enrichment analysis
(Supplementary Table S1) are ‘Ribosome’ (KEGG)
[see (23)]; ‘Translation’ (Reactome); ‘Mitotic cell cycle’
(Reactome); ‘Interleukin-5 immune pathway’ (NetPath);
‘VEGF, hypoxia and angiogenesis’ (BioCarta); as well as
several cancer-related signaling pathways like ‘GPCR sig-
naling’ (Reactome); ‘PDGFR-beta signaling’ (Pathway
Interaction Database); ‘ERK signaling’ (Reactome);
‘RAS signaling’ (Reactome); ‘JAK/STAT signaling’
(INOH). Notably, KEGG’s ‘Non-small cell lung cancer
pathway’ is also among the signiﬁcantly enriched
pathways. Although no Gene Ontology categories were
signiﬁcant at the 0.05 P-value threshold after correction
for multiple testing, among the categories with signiﬁcant
Wilcoxon enrichment P-values (Supplementary Table S1)
are ‘Chromosome organization’, ‘Chromatin assembly’,
‘Regulation of organ growth’ and ‘Mitotic cell cycle’.
As for enriched neighborhood-based entity sets
(Supplementary Table S1), the most signiﬁcantly enriched
one (Wilcoxon signed-rank test P-value=8.34e-6) has
Histone H3-K9 methyltransferase 2 (gene symbol
SUV39H2) as the set center. This neighborhood-based
entity set is constructed from physical interactions and bio-
chemical reactions originating from overall nine different
source databases. The central gene SUV39H2 plays a
crucial role in cell cycle, transcriptional regulation and
cell differentiation [Gene Ontology annotation, UniProt
(24) keywords] and its mutations have been shown to
increase the risk of cancer in human and in mouse
models (25,26). It is important to mention that SUV39H2
itself is not contained in the expression data set that we
uploaded and used for Wilcoxon enrichment analysis, but
many of its network neighbors have expression measure-
ments that show coherent transcriptional dysregulation.
Figure 2 shows the functional interaction neighborhood
sub-network of SUV39H2, where the Yu et al. data are
overlaid on protein nodes as logarithmized gene expression
fold change. To conclude, our results support previous
ﬁndings (27) that utilizing functional interaction data can
substantially improve expression data interpretation and
can point to disease genes that do not come up on the
gene expression analysis level alone. Moreover, our
results underline the importance of data integration as
the SUV39H2-centered sub-network comprises different
types of functional interactions originating from nine inter-
action databases.
Examples for further signiﬁcantly enriched
neighborhood-based entity sets include the ones centered
by ribosomal proteins (e.g., 40S ribosomal protein S4, Y
isoform 2: UniProt: RS4Y2_HUMAN), Nucleosome
assembly complex protein 1-like 4 (UniProt: NP14L_
HUMAN), cell cycle proteins (e.g., MAT1 and MAP
kinase p38 delta: UniProt: MK13_HUMAN) and by the
transcription factor SP1 that, according to UniProt anno-
tation, may modulate the cellular response to DNA
damage.
AVAILABILITY
The Web interface to ConsensusPathDB is freely available
to academic users through http://cpdb.molgen.mpg.de.
The protein interaction part of the ConsensusPathDB
interaction network can be downloaded in tab-delimited
or PSI-MI (28) formats. While the complete database
content is not downloadable due to licensing limitations
imposed by several source databases, we provide a list
of identiﬁers of matching interactions across source data-
bases upon request. Furthermore, we offer web services
for automated pathway analysis of gene expression data.
Through the ConsensusPathDB plugin (29) for the
Cytoscape network visualization and analysis software
(30), experimentalists can automatically mine evidences
for sets of newly detected protein interactions from
ConsensusPathDB and highlight novel interactions
among them. For the interaction data, web services, and
Cytoscape plugin, please visit the ‘data access’ section of
ConsensusPathDB’s Web site.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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